.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
US Department of Justice
Johnson and Johnson
Dow
McKinsey
Citi
Cantor Fitzgerald
QuintilesIMS
Moodys
UBS

Generated: September 21, 2017

DrugPatentWatch Database Preview

Drug Master Files for: sorafenib

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
24578III3/10/2011NATCO PHARMA LTDSORAFENIB TOSYLATE
26460III9/18/2012SICHUAN XIELI PHARMACEUTICAL CO LTDSORAFENIB TOSYLATE
26693AII12/21/2012NATCO PHARMA LTDSORAFENIB TOSYLATE
27793III11/20/2013ZHEJIANG JIUZHOU PHARMACEUTICAL CO LTDSORAFENIB TOSYLATE (VERSION NO.: 1)
28556AII9/23/2014RELIANCE LIFE SCIENCES PVT LTDSORAFENIB TOSYLATE
29340AII6/30/2015YABAO PHARMACEUTICAL GROUP CO LTDSORAFENIB TOSYLATE
29941AII11/29/2015ALEMBIC PHARMACEUTICALS LTDSORAFENIB TOSYLATE
30180AII1/30/2016MSN LABORATORIES PRIVATE LTDSORAFENIB TOSYLATE (FORM-III) [ROUTE CODE SR]
30234AII2/23/2016TEVA PHARMACEUTICAL INDUSTRIES LTDSORAFENIB TOSYLATE
30235AII1/28/2016HETERO LABS LTDSORAFENIB TOSYLATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Teva
Novartis
Fuji
Deloitte
Baxter
Accenture
Cantor Fitzgerald
Colorcon
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot